Share Price and Basic Stock Data
Last Updated: January 21, 2026, 7:08 pm
| PEG Ratio | 52.99 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Andrew Yule & Company Ltd operates in the Plantations sector, specifically focusing on tea and coffee production. As of the latest reporting period, the company’s stock price stood at ₹22.20, with a market capitalization of ₹1,084 Cr. The company has shown fluctuating revenue trends over the past few quarters, with sales recorded at ₹116.07 Cr in September 2022, decreasing to ₹58.58 Cr by June 2023. A slight recovery was noted, with sales rising to ₹87.99 Cr in September 2023. However, the trailing twelve months (TTM) revenue was reported at ₹294 Cr, indicating a decline in overall sales compared to previous periods. The company’s reliance on a narrow product line in a highly competitive market has contributed to these revenue fluctuations, which highlights the need for diversification to stabilize cash flows. Overall, the revenue trajectory reflects ongoing challenges within the sector, necessitating strategic adjustments to enhance growth and market position.
Profitability and Efficiency Metrics
The profitability metrics for Andrew Yule & Company Ltd have been concerning, with a reported operating profit margin (OPM) of -6.45%. The company’s operating profit was ₹21.94 Cr in September 2022, but it turned negative in subsequent quarters, reaching -₹20.81 Cr by June 2023. The net profit stood at ₹5 Cr, translating to a net profit margin of approximately 0.02%. This poor profitability is compounded by a high price-to-earnings (P/E) ratio of 224, which suggests that the market has high expectations that are currently unmet. The return on equity (ROE) was recorded at 7.96%, while the return on capital employed (ROCE) was at 6.83%, both of which are relatively low compared to industry standards. These figures indicate an urgent need for operational improvements and cost management to enhance profitability and investor confidence.
Balance Sheet Strength and Financial Ratios
Andrew Yule & Company Ltd’s balance sheet reflects a mixed picture of financial health. The company reported total borrowings of ₹120 Cr against reserves of ₹264 Cr, indicating a manageable debt level relative to its equity base. However, the interest coverage ratio (ICR) stood at 0.00x, suggesting that the company is unable to meet its interest obligations from its operating income. The current ratio was recorded at 0.66, below the typical industry threshold of 1.0, indicating potential liquidity issues. Additionally, the company’s price-to-book value (P/BV) ratio of 3.71x suggests that the stock is trading at a premium compared to its book value, which is ₹6.93 per share. This indicates that investors are pricing in expectations for future growth, despite current financial challenges. The overall financial ratios highlight the need for a careful evaluation of the company’s capital structure and liquidity management strategies.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Andrew Yule & Company Ltd reveals a strong promoter presence, with promoters holding 89.25% of the total shares. This significant stake indicates a strong commitment from the management; however, it also raises concerns about limited public participation in governance. Foreign institutional investors (FIIs) have remained negligible, holding only 0.00% of the shares, while domestic institutional investors (DIIs) hold 2.20%. The public shareholding is at 8.55%, with a total of 47,115 shareholders. The lack of diversified institutional investment might affect market perception and investor confidence. Furthermore, the declining trend in the number of shareholders from 37,891 in December 2022 to 47,115 in September 2025 suggests a cautious outlook from retail investors. This concentration of ownership could pose risks regarding governance and decision-making processes within the company.
Outlook, Risks, and Final Insight
Looking ahead, Andrew Yule & Company Ltd faces several risks, including operational inefficiencies and high dependency on a limited product line, which could hinder growth prospects. The declining revenue and poor profitability metrics underscore the urgency for strategic initiatives aimed at diversifying product offerings and improving operational efficiency. However, the strong promoter backing provides a degree of stability and potential for turnaround strategies. If the company can effectively manage its debt and improve its interest coverage ratio, it may regain investor confidence. Additionally, enhancing liquidity through better working capital management could mitigate risks associated with cash flow constraints. The future trajectory will depend on the company’s ability to navigate these operational challenges while leveraging its existing strengths to foster sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 333 Cr. | 154 | 275/152 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 | |
| Diana Tea Company Ltd | 40.8 Cr. | 27.2 | 42.0/23.3 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 137 Cr. | 152 | 185/126 | 26.7 | 223 | 0.99 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 10.0 Cr. | 15.9 | 15.9/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 117 Cr. | 377 | 685/354 | 12.5 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,803.41 Cr | 383.92 | 65.90 | 265.00 | 0.44% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 116.07 | 119.98 | 81.14 | 58.58 | 87.99 | 86.72 | 76.57 | 55.53 | 89.42 | 68.33 | 98.43 | 56.14 | 71.52 |
| Expenses | 94.13 | 114.18 | 97.55 | 79.39 | 100.16 | 108.03 | 111.71 | 67.28 | 79.34 | 88.00 | 140.66 | 83.80 | 76.13 |
| Operating Profit | 21.94 | 5.80 | -16.41 | -20.81 | -12.17 | -21.31 | -35.14 | -11.75 | 10.08 | -19.67 | -42.23 | -27.66 | -4.61 |
| OPM % | 18.90% | 4.83% | -20.22% | -35.52% | -13.83% | -24.57% | -45.89% | -21.16% | 11.27% | -28.79% | -42.90% | -49.27% | -6.45% |
| Other Income | 10.86 | 8.68 | 9.03 | 10.01 | 7.58 | 11.67 | 8.81 | 5.23 | 11.14 | 10.36 | 36.82 | 59.71 | 11.00 |
| Interest | 2.12 | 2.76 | 2.86 | 3.25 | 3.18 | 4.31 | 4.76 | 4.62 | 5.07 | 4.36 | -7.48 | 4.99 | 4.41 |
| Depreciation | 1.77 | 1.44 | 1.97 | 1.90 | 1.46 | 1.39 | 2.20 | 1.52 | 1.60 | 1.67 | 17.13 | 1.52 | 1.61 |
| Profit before tax | 28.91 | 10.28 | -12.21 | -15.95 | -9.23 | -15.34 | -33.29 | -12.66 | 14.55 | -15.34 | -15.06 | 25.54 | 0.37 |
| Tax % | 12.80% | 54.96% | -12.61% | 0.00% | -21.34% | -13.75% | -16.49% | -2.45% | 10.72% | -9.26% | -18.53% | 7.28% | 470.27% |
| Net Profit | 20.95 | 6.99 | -5.86 | -7.51 | -5.27 | -12.48 | -22.21 | -2.67 | 14.83 | -14.40 | -0.61 | 20.14 | -0.02 |
| EPS in Rs | 0.43 | 0.14 | -0.12 | -0.15 | -0.11 | -0.26 | -0.45 | -0.05 | 0.30 | -0.29 | -0.01 | 0.41 | -0.00 |
Last Updated: December 28, 2025, 4:30 am
Below is a detailed analysis of the quarterly data for Andrew Yule & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 71.52 Cr.. The value appears strong and on an upward trend. It has increased from 56.14 Cr. (Jun 2025) to 71.52 Cr., marking an increase of 15.38 Cr..
- For Expenses, as of Sep 2025, the value is 76.13 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 83.80 Cr. (Jun 2025) to 76.13 Cr., marking a decrease of 7.67 Cr..
- For Operating Profit, as of Sep 2025, the value is -4.61 Cr.. The value appears strong and on an upward trend. It has increased from -27.66 Cr. (Jun 2025) to -4.61 Cr., marking an increase of 23.05 Cr..
- For OPM %, as of Sep 2025, the value is -6.45%. The value appears strong and on an upward trend. It has increased from -49.27% (Jun 2025) to -6.45%, marking an increase of 42.82%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.71 Cr. (Jun 2025) to 11.00 Cr., marking a decrease of 48.71 Cr..
- For Interest, as of Sep 2025, the value is 4.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.99 Cr. (Jun 2025) to 4.41 Cr., marking a decrease of 0.58 Cr..
- For Depreciation, as of Sep 2025, the value is 1.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.52 Cr. (Jun 2025) to 1.61 Cr., marking an increase of 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 25.54 Cr. (Jun 2025) to 0.37 Cr., marking a decrease of 25.17 Cr..
- For Tax %, as of Sep 2025, the value is 470.27%. The value appears to be increasing, which may not be favorable. It has increased from 7.28% (Jun 2025) to 470.27%, marking an increase of 462.99%.
- For Net Profit, as of Sep 2025, the value is -0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 20.14 Cr. (Jun 2025) to -0.02 Cr., marking a decrease of 20.16 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.00. The value appears to be declining and may need further review. It has decreased from 0.41 (Jun 2025) to 0.00, marking a decrease of 0.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 382 | 372 | 385 | 421 | 367 | 312 | 299 | 330 | 414 | 374 | 310 | 311 | 294 |
| Expenses | 350 | 386 | 381 | 409 | 362 | 330 | 336 | 332 | 423 | 380 | 399 | 374 | 389 |
| Operating Profit | 32 | -14 | 4 | 12 | 6 | -19 | -37 | -2 | -8 | -6 | -89 | -64 | -94 |
| OPM % | 8% | -4% | 1% | 3% | 2% | -6% | -12% | -0% | -2% | -2% | -29% | -20% | -32% |
| Other Income | 11 | 46 | 22 | 42 | 28 | 40 | 29 | 31 | 34 | 32 | 38 | 64 | 118 |
| Interest | 12 | 11 | 10 | 9 | 7 | 6 | 8 | 8 | 8 | 10 | 16 | 22 | 6 |
| Depreciation | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 22 |
| Profit before tax | 26 | 14 | 10 | 38 | 20 | 7 | -23 | 14 | 11 | 9 | -74 | -29 | -4 |
| Tax % | 12% | 7% | 11% | 16% | 32% | 24% | -5% | -46% | 109% | 87% | -13% | -10% | |
| Net Profit | 35 | 46 | 21 | 45 | 22 | 6 | -22 | 35 | -5 | 13 | -47 | -3 | 5 |
| EPS in Rs | 1.08 | 1.38 | 0.63 | 0.93 | 0.46 | 0.11 | -0.44 | 0.72 | -0.11 | 0.26 | -0.97 | -0.06 | 0.11 |
| Dividend Payout % | 0% | 7% | 0% | 11% | 9% | 0% | 0% | 0% | 0% | 3% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.43% | -54.35% | 114.29% | -51.11% | -72.73% | -466.67% | 259.09% | -114.29% | 360.00% | -461.54% | 93.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -85.78% | 168.63% | -165.40% | -21.62% | -393.94% | 725.76% | -373.38% | 474.29% | -821.54% | 555.16% |
Andrew Yule & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 1% |
| 3 Years: | -9% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | % |
| TTM: | 147% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | 8% |
| 1 Year: | -45% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -2% |
| 3 Years: | -6% |
| Last Year: | -8% |
Last Updated: September 5, 2025, 2:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:22 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 65 | 67 | 67 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 |
| Reserves | 239 | 278 | 299 | 238 | 257 | 253 | 245 | 281 | 276 | 287 | 242 | 241 | 264 |
| Borrowings | 94 | 98 | 88 | 41 | 28 | 53 | 81 | 70 | 67 | 100 | 114 | 105 | 120 |
| Other Liabilities | 178 | 189 | 187 | 212 | 187 | 187 | 179 | 187 | 197 | 257 | 257 | 308 | 273 |
| Total Liabilities | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
| Fixed Assets | 181 | 183 | 186 | 81 | 85 | 87 | 94 | 103 | 112 | 142 | 162 | 192 | 191 |
| CWIP | 6 | 5 | 1 | 18 | 37 | 59 | 77 | 75 | 82 | 94 | 88 | 61 | 63 |
| Investments | 97 | 131 | 143 | 169 | 179 | 179 | 202 | 203 | 197 | 201 | 219 | 244 | 240 |
| Other Assets | 292 | 313 | 311 | 321 | 270 | 265 | 228 | 255 | 247 | 305 | 242 | 256 | 261 |
| Total Assets | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
Below is a detailed analysis of the balance sheet data for Andrew Yule & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 98.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 98.00 Cr..
- For Reserves, as of Sep 2025, the value is 264.00 Cr.. The value appears strong and on an upward trend. It has increased from 241.00 Cr. (Mar 2025) to 264.00 Cr., marking an increase of 23.00 Cr..
- For Borrowings, as of Sep 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 105.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 15.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 273.00 Cr.. The value appears to be improving (decreasing). It has decreased from 308.00 Cr. (Mar 2025) to 273.00 Cr., marking a decrease of 35.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 755.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 191.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Mar 2025) to 191.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 240.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Mar 2025) to 240.00 Cr., marking a decrease of 4.00 Cr..
- For Other Assets, as of Sep 2025, the value is 261.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 261.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 755.00 Cr.. The value appears strong and on an upward trend. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
Notably, the Reserves (264.00 Cr.) exceed the Borrowings (120.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.00 | -112.00 | -84.00 | -29.00 | -22.00 | -72.00 | -118.00 | -72.00 | -75.00 | -106.00 | -203.00 | -169.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 107 | 103 | 103 | 79 | 79 | 62 | 70 | 70 | 115 | 118 | 146 |
| Inventory Days | 131 | 104 | 132 | 106 | 156 | 203 | 201 | 185 | 193 | 155 | 109 | 134 |
| Days Payable | 301 | 250 | 281 | 223 | 212 | 227 | 223 | 252 | 231 | 304 | 246 | 351 |
| Cash Conversion Cycle | -74 | -40 | -46 | -15 | 23 | 55 | 40 | 2 | 32 | -33 | -19 | -71 |
| Working Capital Days | -25 | -41 | -27 | 16 | 1 | -26 | -87 | -54 | -10 | -53 | -154 | -187 |
| ROCE % | 10% | 6% | 4% | 7% | 7% | 2% | -4% | 5% | 9% | 4% | -14% | -7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Diluted EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Cash EPS (Rs.) | -0.38 | -1.17 | 0.15 | 0.11 | 0.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Revenue From Operations / Share (Rs.) | 6.38 | 6.34 | 7.65 | 8.47 | 6.76 |
| PBDIT / Share (Rs.) | 0.00 | -1.04 | 0.51 | 0.98 | 0.60 |
| PBIT / Share (Rs.) | -0.13 | -1.18 | 0.38 | 0.85 | 0.46 |
| PBT / Share (Rs.) | -0.58 | -1.50 | 0.18 | 0.22 | 0.30 |
| Net Profit / Share (Rs.) | -0.52 | -1.31 | 0.02 | -0.01 | 0.41 |
| NP After MI And SOA / Share (Rs.) | -0.05 | -0.97 | 0.25 | -0.10 | 0.71 |
| PBDIT Margin (%) | 0.00 | -16.37 | 6.79 | 11.62 | 8.91 |
| PBIT Margin (%) | -2.11 | -18.62 | 5.07 | 10.06 | 6.89 |
| PBT Margin (%) | -9.14 | -23.62 | 2.39 | 2.67 | 4.44 |
| Net Profit Margin (%) | -8.19 | -20.73 | 0.31 | -0.23 | 6.18 |
| NP After MI And SOA Margin (%) | -0.91 | -15.32 | 3.38 | -1.28 | 10.63 |
| Return on Networth / Equity (%) | -0.83 | -13.99 | 3.28 | -1.42 | 9.27 |
| Return on Capital Employeed (%) | -1.69 | -14.42 | 4.18 | 9.57 | 5.42 |
| Return On Assets (%) | -0.37 | -6.68 | 1.70 | -0.83 | 5.52 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.31 | 0.33 | 0.25 | 0.17 | 0.18 |
| Asset Turnover Ratio (%) | 0.42 | 0.42 | 0.63 | 0.76 | 0.62 |
| Current Ratio (X) | 0.66 | 0.70 | 0.98 | 1.11 | 1.09 |
| Quick Ratio (X) | 0.55 | 0.59 | 0.80 | 0.86 | 0.87 |
| Inventory Turnover Ratio (X) | 8.38 | 2.36 | 2.57 | 1.99 | 1.88 |
| Interest Coverage Ratio (X) | 0.00 | -3.27 | 2.54 | 6.04 | 3.64 |
| Interest Coverage Ratio (Post Tax) (X) | -0.16 | -3.11 | 1.12 | 3.72 | 3.62 |
| Enterprise Value (Cr.) | 1325.93 | 1776.01 | 1039.44 | 1022.55 | 967.67 |
| EV / Net Operating Revenue (X) | 4.25 | 5.73 | 2.78 | 2.47 | 2.93 |
| EV / EBITDA (X) | -51194.25 | -35.00 | 40.90 | 21.23 | 32.85 |
| MarketCap / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| Price / BV (X) | 3.71 | 5.01 | 2.57 | 2.64 | 2.55 |
| Price / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| EarningsYield | 0.00 | -0.02 | 0.01 | -0.01 | 0.03 |
After reviewing the key financial ratios for Andrew Yule & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.38. This value is below the healthy minimum of 3. It has increased from -1.17 (Mar 24) to -0.38, marking an increase of 0.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 6.38. It has increased from 6.34 (Mar 24) to 6.38, marking an increase of 0.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has increased from -1.04 (Mar 24) to 0.00, marking an increase of 1.04.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.13. This value is below the healthy minimum of 0. It has increased from -1.18 (Mar 24) to -0.13, marking an increase of 1.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.58. This value is below the healthy minimum of 0. It has increased from -1.50 (Mar 24) to -0.58, marking an increase of 0.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 2. It has increased from -1.31 (Mar 24) to -0.52, marking an increase of 0.79.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 2. It has increased from -0.97 (Mar 24) to -0.05, marking an increase of 0.92.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -16.37 (Mar 24) to 0.00, marking an increase of 16.37.
- For PBIT Margin (%), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 10. It has increased from -18.62 (Mar 24) to -2.11, marking an increase of 16.51.
- For PBT Margin (%), as of Mar 25, the value is -9.14. This value is below the healthy minimum of 10. It has increased from -23.62 (Mar 24) to -9.14, marking an increase of 14.48.
- For Net Profit Margin (%), as of Mar 25, the value is -8.19. This value is below the healthy minimum of 5. It has increased from -20.73 (Mar 24) to -8.19, marking an increase of 12.54.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.91. This value is below the healthy minimum of 8. It has increased from -15.32 (Mar 24) to -0.91, marking an increase of 14.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.83. This value is below the healthy minimum of 15. It has increased from -13.99 (Mar 24) to -0.83, marking an increase of 13.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is -1.69. This value is below the healthy minimum of 10. It has increased from -14.42 (Mar 24) to -1.69, marking an increase of 12.73.
- For Return On Assets (%), as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has increased from -6.68 (Mar 24) to -0.37, marking an increase of 6.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.31, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. There is no change compared to the previous period (Mar 24) which recorded 0.42.
- For Current Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1.5. It has decreased from 0.70 (Mar 24) to 0.66, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 24) to 0.55, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 8. It has increased from 2.36 (Mar 24) to 8.38, marking an increase of 6.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -3.27 (Mar 24) to 0.00, marking an increase of 3.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 3. It has increased from -3.11 (Mar 24) to -0.16, marking an increase of 2.95.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,325.93. It has decreased from 1,776.01 (Mar 24) to 1,325.93, marking a decrease of 450.08.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.25. This value exceeds the healthy maximum of 3. It has decreased from 5.73 (Mar 24) to 4.25, marking a decrease of 1.48.
- For EV / EBITDA (X), as of Mar 25, the value is -51,194.25. This value is below the healthy minimum of 5. It has decreased from -35.00 (Mar 24) to -51,194.25, marking a decrease of 51,159.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For Price / BV (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 5.01 (Mar 24) to 3.71, marking a decrease of 1.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.02 (Mar 24) to 0.00, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Andrew Yule & Company Ltd:
- Net Profit Margin: -8.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -1.69% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.83% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.16
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.55
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 215 (Industry average Stock P/E: 65.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.31
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -8.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Yule House, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ananta Mohan Singh | Chairman & Managing Director |
| Mr. Sanjay Verma | Director - Finance |
| Mr. Sunder Pal Singh | Ind. Non-Executive Director |
| Ms. Swapna Tripathy | Ind. Non-Executive Director |
| Mr. Vijay Mittal | Nominee Director |
| Mr. Brajesh Kumar Srivastava | Nominee Director |
FAQ
What is the intrinsic value of Andrew Yule & Company Ltd?
Andrew Yule & Company Ltd's intrinsic value (as of 21 January 2026) is ₹107.39 which is 404.18% higher the current market price of ₹21.30, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,040 Cr. market cap, FY2025-2026 high/low of ₹40.1/21.0, reserves of ₹264 Cr, and liabilities of ₹755 Cr.
What is the Market Cap of Andrew Yule & Company Ltd?
The Market Cap of Andrew Yule & Company Ltd is 1,040 Cr..
What is the current Stock Price of Andrew Yule & Company Ltd as on 21 January 2026?
The current stock price of Andrew Yule & Company Ltd as on 21 January 2026 is ₹21.3.
What is the High / Low of Andrew Yule & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Andrew Yule & Company Ltd stocks is ₹40.1/21.0.
What is the Stock P/E of Andrew Yule & Company Ltd?
The Stock P/E of Andrew Yule & Company Ltd is 215.
What is the Book Value of Andrew Yule & Company Ltd?
The Book Value of Andrew Yule & Company Ltd is 7.39.
What is the Dividend Yield of Andrew Yule & Company Ltd?
The Dividend Yield of Andrew Yule & Company Ltd is 0.00 %.
What is the ROCE of Andrew Yule & Company Ltd?
The ROCE of Andrew Yule & Company Ltd is 6.83 %.
What is the ROE of Andrew Yule & Company Ltd?
The ROE of Andrew Yule & Company Ltd is 7.96 %.
What is the Face Value of Andrew Yule & Company Ltd?
The Face Value of Andrew Yule & Company Ltd is 2.00.